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ABSTRACT
Objectives To determine clinical and ultrasonographic 
predictors of joint replacement surgery across Europe in 
primary osteoarthritis (OA) of the knee.
Methods This was a 3-year prospective study of a painful 
OA knee cohort (from a EULAR-sponsored, multicentre 
study). All subjects had clinical evaluation, radiographs 
and ultrasonography (US) at study entry. The rate of knee 
replacement surgery over the 3-year follow-up period was 
determined using Kaplan–Meier survival data analyses. 
Predictive factors for joint replacement were identifi ed by 
univariate log-rank test then multivariate analysis using 
a Cox proportional-hazards regression model. Potential 
baseline predictors included demographic, clinical, 
radiographic and US features.
Results Of the 600 original patients, 531 (88.5%), mean 
age 67±10 years, mean disease duration 6.1±6.9 years, 
had follow-up data and were analysed. During follow-up 
(median 3 years; range 0–4 years), knee replacement 
was done or required for 94 patients (estimated event 
rate of 17.7%). In the multivariate analysis, predictors of 
joint replacement were as follows: Kellgren and Lawrence 
radiographic grade (grade ≥III vs <III, hazards ratio (HR) = 
4.08 (95% CI 2.34 to 7.12), p<0.0001); ultrasonographic 
knee effusion (≥4 mm vs <4 mm) (HR = 2.63 (95% CI 
1.70 to 4.06), p<0.0001); knee pain intensity on a 0–100 
mm visual analogue scale (≥60 vs <60) (HR = 1.81 (95% 
CI 1.15 to 2.83), p=0.01) and disease duration (≥5 years 
vs <5 years) (HR=1.63 (95% CI 1.08 to 2.47), p=0.02). 
Clinically detected effusion and US synovitis were not 
associated with joint replacement in the univariate analysis.
Conclusion Longitudinal evaluation of this OA 
cohort demonstrated signifi cant progression to joint 
replacement. In addition to severity of radiographic 
damage and pain, US-detected effusion was a predictor 
of subsequent joint replacement.
INTRODUCTION
Osteoarthritis (OA) of the knee is a major problem 
for ageing Western populations.1 A major part of 
the economic burden is related to joint replacement 
surgery.2 It would be advantageous to have predic-
tors of subsequent joint replacement in order to pri-
oritise research in these patients, examine reversible 
risk factors and provide cohorts for evaluating puta-
tive disease-modifying treatments.3 The limited 
prospective studies on joint replacement for OA 
suggest that radiographic severity, pain and global 
disease assessments, and willingness to consider 
surgery are the strongest predictors of subsequent 
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joint replacement surgery.4 5 Such research high-
lights the complexity of joint replacement as an 
outcome measure in clinical trials, as patient per-
ceptions of the need for surgery and potential side 
effects affect willingness to undergo a procedure; 
socioeconomic features are important and these 
factors are reﬂ ected in regional and national varia-
tions in use of joint replacement.3 5
Previous work has demonstrated the prevalence 
of synovitis in OA,6 and studies of predictors of 
joint replacement have been unable to adequately 
evaluate the inﬂ ammatory component of OA as 
they did not employ modern imaging techniques 
such as ultrasonography (US), which are the most 
sensitive way of evaluating the presence of syno-
vitis. The importance of such synovitis in disease 
progression or its relationship to subsequent need 
for joint replacement is not clear.
We have previously reported the results of a 
large, cross-sectional, multinational EULAR study 
that employed clinical examination and US in a 
cohort with painful OA of the knee.7 This study 
demonstrated that synovial inﬂ ammation (either 
synovial hypertrophy or effusion) was very com-
mon and much more frequently detected with 
US than by clinical examination (47% vs 30%). 
However, it was not possible to derive useful clin-
ical decision rules by which to identify patients 
with synovial inﬂ ammation,8 suggesting that only 
an imaging technique such as US will be useful in 
identifying these patients.
The aim of this study was to prospectively fol-
low-up this EULAR cohort of patients with pain-
ful OA of the knee and determine the rate of joint 
replacement at 3 years and the factors predicting 
surgery; in particular, whether US ﬁ ndings of syno-
vial inﬂ ammation would be predictive of subse-
quent surgery. Joint replacement was judged by the 
performance of partial or total joint arthroplasty 
and also by patients being listed for surgery, or 
being considered as deserving of such surgery but 
being medically unﬁ t.
PATIENTS AND METHODS
Patients
The cohort followed up in this study was from a 
multicentre European study conducted under the 
umbrella of the EULAR Standing Committee for 
International Clinical Studies Including Therapeutics 
Trials (ESCISIT), enrolling subjects from seven 
European countries (Belgium, France, Germany, 
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Italy, Spain, Switzerland and the UK) who were recruited by 
50 rheumatologists.7 Appropriate ethics committee permission 
was obtained in each country and written informed consent was 
obtained from every patient before study participation. The main 
inclusion criteria were as follows: age ≥18, primary knee OA 
according to the American College of Rheumatology deﬁ nition,9 
with radiographic Kellgren and Lawrence (K&L) grade 1–4,10 11 
symptoms of at least 6 months’ duration, functional capacity 1–3 
according to the Steinbrocker functional score12 and pain inten-
sity at study entry ≥30 mm on a 100 mm visual analogue scale 
that asked about pain in the previous 48 h related to physical 
activities. Exclusion criteria included any known cause for sec-
ondary OA, inﬂ ammatory arthritis, recurrent pseudogout and 
surgery on the study joint within the previous 12 months.
Methods
At baseline, all patients were examined by a rheumatologist, 
then a radiologist or second rheumatologist performed US of 
the study knee according to prespeciﬁ ed US parameters (details 
in D’Agostino et al7). Data were recorded by the investigators on 
two separate case report forms that were forwarded to a central 
data entry and quality-control service. Subsequently, the patients 
were invited for annual review, where information was recorded 
on whether joint replacement (total or unicompartmental) had 
been performed, or whether the patient had been listed for such 
surgery, or whether such surgery would have been performed if 
the patient had been medically ﬁ t.
Statistical analysis
Descriptive statistics were calculated for follow-up characteris-
tics of the overall cohort, as well as the percentage of patients 
having knee replacement performed/required. The survival 
analysis was performed on all subjects with at least one con-
tact. In order to determine the rate of joint replacement over the 
3-year follow-up for the overall population, a survival curve was 
established using the Kaplan–Meier estimator. For subjects who 
were not prescribed knee replacement, the following censoring 
rules were applied: subjects who did not require knee replace-
ment after years 1, 2 and 3 were censored at the date of contact 
of year 3; subjects who did not require knee replacement at year 
1 and for whom no data were available at year 2 (no contact 
or missing data concerning knee replacement) were censored at 
date of contact of year 1; and subjects who did not require knee 
replacement at year 2 and for whom no data were available at 
year 3 (no contact or missing data concerning knee replacement) 
were censored at date of contact of year 2.
The relationship between prescription of knee replacement 
and baseline characteristics was evaluated and no missing data 
were replaced, so only complete observations were used in the 
analyses. Predictive factors for joint replacement at 3 years were 
identiﬁ ed by univariate analysis using a log-rank test and HR. All 
pertinent patients’ baseline characteristics identiﬁ ed in the uni-
variate analysis (p<0.20) were integrated in a multivariate analy-
sis (Cox proportional-hazards regression model) in which the 
dependent variable was the time to performance/requirement 
for knee replacement, and the independent variables were the 
signiﬁ cant patient characteristics.
RESULTS
Of 643 subjects enrolled in the study, 600 patients were analy-
sed in the cross-sectional part of the study (16 were missing a 
case report from either clinical examination or ultrasound and 
27 had major protocol deviations). Out of these, 565 patients 
entered the extension phase and had at least one follow-up visit: 
of these, 33 could not be contacted for the 3-year follow up and 
one patient was excluded because the studied knee at follow-up 
was different from baseline. Therefore at 3 years, 531 patients 
were analysed, including 94 patients (18%) with a knee replace-
ment done (64 (12%)) or required (30 (6%)). Six of the knee 
operations were unicompartmental replacements.
The baseline characteristics of those completing 3 years of 
follow-up are presented in table 1, with the annual requirement 
for surgery according to deﬁ ned surgical end points presented 
in table 2. The 3-year survival rate was 82.3% (standard error 
0.017). The survival curve is presented in ﬁ gure 1.
The baseline characteristics included and the results for 
the univariate analysis are presented in table 3. Of note, the 
WOMAC physical function subscale, age, clinical joint effusion, 
body mass index, gender, night awakening due to knee pain and 
Figure 1 Survival curve for knee replacement.




Age (years) (mean±SD) 67±10
Women (% of cohort) 72.5
BMI (kg/m2, mean±SD) 30±5
BMI <30 kg/m2 (%) 55.6
Disease duration (years) 6±7
Pain on VAS (mm) 63±18
K&L score:
 Grade ≤2 (% patients) 44.6
 Grade 3–4 (% patients) 55.4
Joint effusion (moderate–severe) at clinical examination (% patients) 34.1
US hydarthrodial effusion (% patients with effusion depth ≥4 mm) 41.3
US synovitis (% patients with synovial thickness ≥4 mm and diffuse or 
nodular appearance)
16.6
BMI, body mass index; K&L, Kellgren and Lawrence; US, ultrasonography; VAS, visual 
analogue scale.





performed Indication for surgery Total
Year 0–year 1 44 (8) 20 (4) 64 (12)
Year 0–year 2 53 (10) 26 (5) 79 (15)
Year 0–year 3 64 (12)* 30 (6) 94 (18)
n=31 analysed at year 3.
*Six had a unicompartmental knee replacement.
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DISCUSSION
This longitudinal study of painful knee OA has conﬁ rmed the 
importance of the extent of radiographic damage and patient 
symptoms in predicting subsequent need for joint replacement. 
In addition, it has demonstrated for the ﬁ rst time that an US fea-
ture of synovial inﬂ ammation, the US effusion, is also an inde-
pendent predictor of joint replacement.
This study does not of course imply causation—that is, that 
synovial inﬂ ammation causes symptomatic/structural deteriora-
tion leading to joint replacement. The presence of joint inﬂ am-
mation may just reﬂ ect structural OA severity: it is plausible that 
synovial inﬂ ammation is associated with the degree of chon-
dropathy, and increased levels of synovitis have been associ-
ated with more advanced cartilage loss.6 Synovial effusion and 
hypertrophy on MRI have also been associated with knee pain 
in OA.13 14
It is not surprising that US-detected effusion, but not clini-
cally detected effusion, was a predictor of the outcome; we 
have previously demonstrated the increased sensitivity of US 
for this inﬂ ammatory feature.7 However, it may appear confus-
ing that effusion but not synovial hypertrophy was associated 
with subsequent joint replacement need. Our previous work7 
also demonstrated that larger effusions generally meant greater 
degree of synovial hypertrophy. However, because of the mul-
tiple ultrasonographer requirement for this multicentre study, 
we employed a conservative deﬁ nition of synovial hypertrophy 
that may have made it difﬁ cult to demonstrate an association 
with synovial hypertrophy. A possible limitation of this work 
is that the ultrasound assessment included was only performed 
at a single time point; although anecdotal clinical reports sug-
gest that inﬂ ammation varies over time in OA, little has been 
reported on the longitudinal evaluation of synovitis using sensi-
tive imaging modalities.
Using joint replacement as an outcome measure for OA is of 
course a complex issue that relates to national and local health 
priorities, individual surgeon choices, as well as patient will-
ingness and comorbidities.3 15 One limitation of this study is 
therefore the pragmatic outcome we have chosen. Additionally, 
we did not measure psychosocial factors such as anxiety and 
depression to assess their role in prediction. Certainly there is 
no international consensus on when joint replacement should 
be considered, and an ongoing OMERACT–OARSI initiative is 
developing a multidomain tool that will allow agreement on the 
level of OA severity that will act as a surrogate measure for the 
need for joint replacement.16
In summary, this large cohort of patients with painful knee 
OA has conﬁ rmed the importance of presenting features of pain 
and radiographic damage in predicting subsequent need for joint 
replacement. But it has also demonstrated that the presence of a 
large US-detected effusion may also be included in clinical mod-
els to predict surgical need.
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US synovitis were not associated with joint replacement in the 
univariate analysis.
The following features were included in the multivariate 
analysis: K&L radiological grade; US knee effusion; physi-
cian’s global assessment of clinical knee OA severity; knee pain 
intensity; patient’s global assessment of clinical knee OA; dis-
ease duration; US knee synovitis; WOMAC stiffness and pain 
subscales. The ﬁ nal predictors of joint replacement were K&L 
radiographic grade (HR=4.08 (95% CI 2.34 to 7.12), p<0.0001); 
ultrasonographic knee effusion (HR=2.63 (95% CI 1.70 to 4.06), 
p<0.0001); knee pain intensity on a 0–100 mm visual analogue 
scale (HR=1.81 (95% CI 1.15 to 2.83), p=0.01) and disease dura-
tion (HR=1.63 (95% CI 1.08 to 2.47), p=0.02). Table 4 presents 
the baseline characteristics of these ﬁ nal predictors.
Table 3 Characteristics included and results of the univariate analysis
 HR (95% CI) p Value
Sex 1.10 (0.71 to 1.72) 0.6582
Age 1.24 (0.81 to 1.89) 0.3144
BMI 1.15 (0.76 to 1.73) 0.5121
Disease duration 1.70 (1.13 to 2.55) 0.0109
K&L radiological grade 4.67 (2.73 to 8.01) <0.0001
Knee pain intensity on VAS 1.82 (1.17 to 2.82) 0.0074
Joint effusion at clinical examination 1.15 (0.75 to 1.76) 0.5153
Sudden aggravation of knee pain 0.74 (0.49 to 1.13) 0.1617
Duration of morning stiffness 1.41 (0.86 to 2.32) 0.1686
Night awakening due to knee pain 1.07 (0.69 to 1.65) 0.7730
WOMAC pain subscale 1.45 (0.94 to 2.22) 0.0894
WOMAC stiffness subscale 1.36 (0.88 to 2.08) 0.1614
WOMAC function subscale 1.27 (0.81 to 2.00) 0.3053
Patient’s global assessment of clinical knee 
OA severity on VAS
1.46 (0.95 to 2.25) 0.0832
Physician’s global assessment of clinical 
knee OA severity on VAS
1.88 (1.24 to 2.84) 0.0031
Ultrasonographic knee effusion depth 3.06 (2.00 to 4.69) <0.0001
Ultrasonographic knee synovitis 1.54 (0.95 to 2.50) 0.0826
BMI, body mass index; HR, hazard ratio; K&L, Kellgren and Lawrence; OA, osteoarthritis; 
VAS, visual analogue scale; WOMAC, Western Ontario and McMaster Universities 
Osteoarthritis Index.












 n 437 94 531
 Grade 0–2 221 (50.6) 16 (17.0) 237 (44.6)
 Grade 3–4 216 (49.4) 78 (83.0) 294 (55.4)
 Missing data   0  0   0
Ultrasonographic knee effusion depth
 n 436 94 530
 <4 mm 279 (64.0) 32 (34.0) 311 (58.7)
 ≥4 mm 157 (36.0) 62 (66.0) 219 (41.3)
 Missing data   1  0   1
Knee pain intensity on VAS
 n 436 94 530
 <60 mm 194 (44.5) 29 (30.9) 223 (42.1)
 ≥60 mm 242 (55.5) 65 (69.1) 307 (57.9)
 Missing data   1  0   1
Disease duration
 n 435 94 529
 <5 Years 259 (59.5) 42 (44.7) 301 (56.9)
 ≥5 Years 176 (40.5) 52 (55.3) 228 (43.1)
 Missing data   2  0   2
Results are shown as number or number (%).
K&L, Kellgren and Lawrence; VAS, visual analogue scale.
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